TARDBP and neurodegenerative disease: Since the initial discovery that TDP-43 forms phosphorylated (pTDP-43), intracellular aggregates in neurodegenerative diseases, several studies have demonstrated that TDP-43 aggregates can promote toxicity through toxic gain-of-function mechanisms14–16.